Ultragenyx Pharmaceutical Inc. (RARE) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/13/26
RARE Q1 Loss Wider Than Expected, Sales Down Y/Y on Seasonal EffectZacks Investment Research • 05/06/26
Ultragenyx (RARE) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/05/26
Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate UpdateGlobeNewsWire • 04/29/26
Will Ultragenyx (RARE) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 04/28/26
RARE CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026Newsfile Corp • 04/08/26
RARE DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARENewsfile Corp • 04/06/26
RARE Rises as FDA Accepts Resubmitted BLA for Sanfilippo SyndromeZacks Investment Research • 04/06/26
RARE FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026Business Wire • 04/06/26
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law FirmGlobeNewsWire • 04/06/26
Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RAREPRNewsWire • 04/06/26
RARE DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RAREGlobeNewsWire • 04/05/26
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewsWire • 04/05/26
RARE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARENewsfile Corp • 04/05/26
RARE INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026Newsfile Corp • 04/05/26
RARE Deadline: RARE Investors with Losses in Excess of $100K Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud LawsuitPRNewsWire • 04/04/26
RARE DEADLINE MONDAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARENewsfile Corp • 04/04/26
RARE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026PRNewsWire • 04/04/26
Ultragenyx 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RAREBusiness Wire • 04/03/26